Advice You - Business

Relationships are based on trust—not just romantic relationships,

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

or doctor/patient relationships, but practically any relationshi

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

, even the one with your auto mechanic.

That's why the absolute

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

orst thing a financial planner can do in their relationship with

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

reporter—especially a new relationship—is to give them false inf

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

rmation.

Remember, they think of you as a subject matter expert.

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

Someone they can turn to again and again for concise, intelligen

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

and accurate explanations for financial planning matters that th

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

y don't understand. If you mislead them, even if it's unintention

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

l, you lose all credibility--and all chances for publicity.

It i

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

an especially egregious mistake to make with a reporter, because

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

they have a relationship with their readers. If they print the f

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

lse information that you gave them, it gets into the hands of tho

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

sands of people.

When the mistake is caught (and it will be) the

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

reporter has to print an embarrassing correction or retraction. B

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

lieve me, your number will be gone from their Rolodex in an insta

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

nt.

If you are not sure of the answer to a reporter’s question,

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ay these words: "I'm not sure, let me check." This sentence is th

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

only acceptable response. Winging it will invariably get you in

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

rouble. Tell the reporter you’ll look into it, and call back soon

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/34002/adviceyou-Financial-Planning-Publicity-When-Talking-to-the-Media-Dont-Fake-What-You-Dont-Know.html">Financial Planning Publicity: When Talking to the Media, Don't Fake What You Don't Know</a>

BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/34002/adviceyou-Financial-Planning-Publicity-When-Talking-to-the-Media-Dont-Fake-What-You-Dont-Know.html]Financial Planning Publicity: When Talking to the Media, Don't Fake What You Don't Know[/url]

Has the Federal Trade Commission run amuck? Indeed it has, it has become a problematic bureaucracy. The Federal Trade Commission lacks free market thinking. I always assumed that half of the Federal Trade Commissions staff are attorneys and the other half are economists.

Think about the time and energy you are giving to your professional life. Are you getting out of it what you expected?

Motivation and simplicity: these are marketing tools you can use to win in the marketplace.

Tags

Links

Advice You - Financial Planning Publicity: When Talking to the Media, Don't Fake What You Don't Know

Related Articles: